Abstract
Between September 1981 and November 1984 the Danish Ovarian Cancer Group (DACOVA) performed two randomised trials. One for adjuvant therapy in stages Ib, Ic and II and one for chemotherapy treatment in stages III and IV. One hundred and twenty patients fulfilled criteria for the early stage protocol but only 60% was randomised. Three hundred and sixty-one fulfilled criteria for the advanced stages protocol, 73% was randomised. In early stages 11% were excluded because of unavoidable reasons and 29% because of avoidable reasons. In contrast, in advanced stages 21% were excluded because of unavoidable reasons and only 6% because of avoidable reasons. Allocation to the early stage protocol varied with stage, histologic type, residual tumour, and the presence of ascites. These factors had no influence upon allocation to the advanced stages protocol. The experience from this study is: only essential and simple questions should be examined in multicentre trials. Patient accrual and the difference between randomisation groups are usually overestimated, large scale trials are often required to get statistically significant differences, and the participation of departments only randomising a small and selected part of their patients is questionable.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Andersen K. W., Mouridsen H. T. Danish Breast Cancer Cooperative Group (DBCG). A description of the register of the nation-wide programme for primary breast cancer. Acta Oncol. 1988;27(6A):627–647. doi: 10.3109/02841868809091763. [DOI] [PubMed] [Google Scholar]
- Bertelsen K., Jakobsen A., Andersen J. E., Ahrons S., Pedersen P. H., Kiaer H., Arffmann E., Bichel P., Boestofte E., Strøyer I. A randomized study of cyclophosphamide and cis-platinum with or without doxorubicin in advanced ovarian carcinoma. Gynecol Oncol. 1987 Oct;28(2):161–169. doi: 10.1016/0090-8258(87)90210-1. [DOI] [PubMed] [Google Scholar]
- Dembo A. J., Van Dyk J., Japp B., Bean H. A., Beale F. A., Pringle J. F., Bush R. S. Whole abdominal irradiation by a moving-strip technique for patients with ovarian cancer. Int J Radiat Oncol Biol Phys. 1979 Nov-Dec;5(11-12):1933–1942. doi: 10.1016/0360-3016(79)90942-8. [DOI] [PubMed] [Google Scholar]
- Mauch P. M., Ehrmann R. L., Griffiths C. T., Marck A., Knapp R. C., Levene M. B. Radiation therapy in stage II ovarian carcinoma: the influence of histologic grade. Cancer. 1980 Mar 15;45(6):1344–1351. doi: 10.1002/1097-0142(19800315)45:6<1344::aid-cncr2820450613>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
- Scully R. E. Ovarian tumors. A review. Am J Pathol. 1977 Jun;87(3):686–720. [PMC free article] [PubMed] [Google Scholar]
- Sell A., Bertelsen K., Andersen J. E., Strøyer I., Panduro J. Randomized study of whole-abdomen irradiation versus pelvic irradiation plus cyclophosphamide in treatment of early ovarian cancer. Gynecol Oncol. 1990 Jun;37(3):367–373. doi: 10.1016/0090-8258(90)90369-v. [DOI] [PubMed] [Google Scholar]